7.26
2.40%
0.17
시간 외 거래:
7.18
-0.08
-1.10%
전일 마감가:
$7.09
열려 있는:
$7.02
하루 거래량:
1.75M
Relative Volume:
0.75
시가총액:
$2.00B
수익:
$248.37M
순이익/손실:
$11.74M
주가수익비율:
-38.21
EPS:
-0.19
순현금흐름:
$18.24M
1주 성능:
+5.68%
1개월 성능:
+11.86%
6개월 성능:
+65.38%
1년 성능:
+83.33%
맨카인드 Stock (MNKD) Company Profile
명칭
Mannkind Corp
전화
818-661-5000
주소
1 CASPER STREET, DANBURY, CA
맨카인드 Stock (MNKD) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-10-10 | 개시 | Wedbush | Outperform |
2021-05-14 | 개시 | RBC Capital Mkts | Sector Perform |
2019-12-24 | 개시 | Oppenheimer | Outperform |
2019-10-25 | 개시 | Cantor Fitzgerald | Overweight |
2019-05-14 | 개시 | BTIG Research | Buy |
2019-03-04 | 개시 | SVB Leerink | Outperform |
2019-02-22 | 개시 | SVB Leerink | Outperform |
2018-02-28 | 다운그레이드 | Maxim Group | Hold → Sell |
2017-11-01 | 다운그레이드 | Maxim Group | Buy → Hold |
2017-10-10 | 개시 | H.C. Wainwright | Buy |
2017-10-06 | 재확인 | Maxim Group | Buy |
2017-08-11 | 개시 | Maxim Group | Buy |
2016-05-10 | 재확인 | Piper Jaffray | Underweight |
2016-05-10 | 재확인 | RBC Capital Mkts | Underperform |
2016-01-06 | 재확인 | Piper Jaffray | Underweight |
2016-01-06 | 재확인 | RBC Capital Mkts | Underperform |
2015-11-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Underperform |
2015-09-09 | 다운그레이드 | Piper Jaffray | Neutral → Underweight |
2015-08-03 | 재확인 | RBC Capital Mkts | Outperform |
2015-05-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2015-05-11 | 재확인 | MLV & Co | Hold |
2015-04-16 | 재확인 | RBC Capital Mkts | Outperform |
모두보기
맨카인드 주식(MNKD)의 최신 뉴스
MannKind (NASDAQ:MNKD) Reaches New 1-Year HighHere's What Happened - MarketBeat
MannKind Shares Soar to Over 8-Year Highs on United Therapeutics’ Tyvaso Revenue Surge: Retail Is Optimistic - MSN
MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease - ForexTV.com
MannKind (NASDAQ:MNKD) Sets New 1-Year HighTime to Buy? - MarketBeat
MannKind stock soars to 52-week high, touches $6.93 - Investing.com
MannKind Co. (NASDAQ:MNKD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
MannKind Corporation Reports 2012 Fourth Quarter and Full Year Financial Results - AOL
SG Americas Securities LLC Takes Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
Mannkind Corp (MNKD) receives an Outperform rating from Leerink Partners - Knox Daily
Recent Insider Activity Could Benefit 3M Co. (MMM) - Knox Daily
Holdings of Mannkind Corp (MNKD) are aligned with the stars - SETE News
Selling Buzz: Mannkind Corp [MNKD] Chief People & Workpl Officer Tross Stuart A sells 25,000 shares of the company - Knox Daily
Ratios Revealed: Decoding Mannkind Corp (MNKD)’s Financial Health - The Dwinnex
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... By GuruFocus - Investing.com Canada
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Pipeline ... - Yahoo Finance
MannKind Corp (MNKD) Q2 2024 Earnings Call Highlights: Record Re - GuruFocus.com
Did Mannkind Corp (MNKD) perform well in the last session? - US Post News
Potential Price Increase for Mannkind Corp (MNKD) After Recent Insider Activity - Knox Daily
Mannkind Corp (MNKD) can make a big difference with a little luck - SETE News
Squarepoint Ops LLC Sells 133,926 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
Why MannKind (MNKD) Could Beat Earnings Estimates Again - Yahoo Finance
MannKind (MNKD) Just Overtook the 20-Day Moving Average - Yahoo Finance
MannKind Co. (NASDAQ:MNKD) Shares Purchased by Millennium Management LLC - MarketBeat
Exploring High Growth Tech Stocks In The United States October 2024 - Yahoo Finance
MannKind (NASDAQ:MNKD) Shares Up 3.2% - MarketBeat
MannKind Leverages Tyvaso DPI Strength In Pulmonary Market Expansion - Seeking Alpha
Marshall Wace LLP Sells 205,764 Shares of MannKind Co. (NASDAQ:MNKD) - MarketBeat
A better buy-in window may exist right now for Mannkind Corp (MNKD) - SETE News
MannKind's SWOT analysis: inhaled therapeutics firm's stock shows promise amid challenges - Investing.com
More Adults With Type 1 Diabetes Achieved A1C Goal ( - Yahoo Finance
MannKind Co. (NASDAQ:MNKD) Shares Bought by Dark Forest Capital Management LP - MarketBeat
Mannkind Corp (MNKD)’s results reveal risk - US Post News
The Attractiveness of Investing In Mind Medicine Inc (MNMD) is Growing - Knox Daily
A new trading data show Mannkind Corp (MNKD) is showing positive returns. - SETE News
MNKD stock rated an Outperform by Leerink Partners - Knox Daily
Closing Figures: Mind Medicine Inc (MNMD)’s Negative Finish at 5.87, Down -1.68 - The Dwinnex
Manba Finance IPO Sees Stellar 73.18 Times Subscription on Second Day - Devdiscourse
Manba Finance IPO subscribed 73.18 times on Day 2 amid heavy demand from institutional investors - NewsDrum
Latest News - LatestLY
Mind Medicine Inc (MNMD) produces promising results - US Post News
Stock market update: Nifty Pharma index advances 0.23% - The Economic Times
Manba Finance IPO continues to attract great interest, subscribed 73 times on day 2 - Moneycontrol
Manba Finance IPO subscribed 56 times so far on Day 2 - Indiainfoline
Manba Finance IPO Day 2: Issue subscribed 41.11 times so far, check key dates and more - Upstox
Manaba Finance IPO Day 2: Check latest subscription, expected listing gains - India Today
Mankind Pharma To Raise Rs 7,000-Crore Debt For Bharat Serums Acquisition - NDTV Profit
Stock to buy today: Mankind Pharma (₹2,651.30): BUY - BusinessLine
Trade Spotlight: How should you trade Siemens, Mankind Pharma, Kotak Bank, DLF, Indegene and others on... - Moneycontrol
Avoro Capital Advisors LLC Reduces Stock Position in MannKind Co. (NASDAQ:MNKD) - MarketBeat
Manba Finance Limited IPO Subscribed 23.67 Times on Day 1 of Bidding, Sale To Conclude on September 25; - LatestLY
맨카인드 (MNKD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):